Pharma Industry News

Plaque psoriasis study claims Tremfya superior to Cosentyx

Janssen’s plaque psoriasis treatment Tremfya was found to be superior to Novartis' Cosentyx in treating adults with moderate-to-severe cases of the condition, according to findings of a late-stage study.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]